There is provided a compound of formula (I); or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
申请公布号
WO2008075068(A3)
申请公布日期
2008.10.02
申请号
WO2007GB04917
申请日期
2007.12.20
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;FOOTE, KEVIN, MICHAEL;THEOCLITOU, MARIA-ELENA;THOMAS, ANDREW, PETER;BUTTAR, DAVID
发明人
FOOTE, KEVIN, MICHAEL;THEOCLITOU, MARIA-ELENA;THOMAS, ANDREW, PETER;BUTTAR, DAVID
